Utility of Examination of Biopsy Tracts in Osteosarcoma Resection Specimens.

Cates JM
Am J Clin Pathol. 2016 146 (3): 324-7

PMID: 27543978 · DOI:10.1093/ajcp/aqw119

OBJECTIVES - To determine the utility and necessity of submitting tissue sections from the biopsy tracts of osteosarcoma resection specimens.

METHODS - The prevalence of residual tumor in representative sections of osteosarcoma biopsy tracts was assessed in a series of 97 osteosarcoma resection specimens.

RESULTS - No residual tumor cells were identified in 97 sampled biopsy tracts (0%; 95% confidence interval, 0%-2.5%).

CONCLUSIONS - Pathologists do not need to submit sections of resected biopsy tracts unless there is clinical or gross evidence that would warrant further examination.

© American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

MeSH Terms (5)

Biopsy Bone Neoplasms Humans Neoplasm, Residual Osteosarcoma

Connections (1)

This publication is referenced by other Labnodes entities: